Originales
Eficacia y seguridad de asociar ezetimiba a dosis bajas de atorvastatina en la hipercolesterolemia asociada al tratamiento antirretroviral en pacientes con el virus de la inmunodeficiencia humana
Efficacy and Safety of Adding Ezetimibe to Low-Dose Atorvastatin for Highly Active Antiretroviral Therapyrelated Hypercholesterolaemia
Rosario Palacios Muñoza, Susana Puerta Fernándezb, Ana Hidalgo Condeb, Josefa Ruiz Moralesa, Mercedes González Serranoa, Manuel Márquez Soleroa, Jesús Santos Gonzáleza,
Autor para correspondencia
med000854@gmail.com
Dr. J. Santos González. Unidad de Enfermedades Infecciosas. Hospital Virgen de la Victoria. Campus Teatinus, s/n. 29010 Málaga. España.
Dr. J. Santos González. Unidad de Enfermedades Infecciosas. Hospital Virgen de la Victoria. Campus Teatinus, s/n. 29010 Málaga. España.
Leído
4765
Vecesse ha leído el artículo
632
Total PDF
4133
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 10 | 4 | 14 |
| 2025 11 | 38 | 26 | 64 |
| 2025 10 | 39 | 10 | 49 |
| 2025 9 | 36 | 10 | 46 |
| 2025 8 | 40 | 21 | 61 |
| 2025 7 | 29 | 6 | 35 |
| 2025 6 | 55 | 4 | 59 |
| 2025 5 | 38 | 2 | 40 |
| 2025 4 | 41 | 4 | 45 |
| 2025 3 | 31 | 4 | 35 |
| 2025 2 | 39 | 3 | 42 |
| 2025 1 | 23 | 3 | 26 |
| 2024 12 | 45 | 0 | 45 |
| 2024 11 | 40 | 3 | 43 |
| 2024 10 | 46 | 3 | 49 |
| 2024 9 | 42 | 4 | 46 |
| 2024 8 | 38 | 2 | 40 |
| 2024 7 | 33 | 1 | 34 |
| 2024 6 | 47 | 2 | 49 |
| 2024 5 | 52 | 2 | 54 |
| 2024 4 | 27 | 4 | 31 |
| 2024 3 | 35 | 5 | 40 |
| 2024 2 | 29 | 4 | 33 |
| 2024 1 | 55 | 5 | 60 |
| 2023 12 | 32 | 3 | 35 |
| 2023 11 | 36 | 3 | 39 |
| 2023 10 | 48 | 10 | 58 |
| 2023 9 | 31 | 0 | 31 |
| 2023 8 | 20 | 0 | 20 |
| 2023 7 | 28 | 2 | 30 |
| 2023 6 | 41 | 2 | 43 |
| 2023 5 | 56 | 1 | 57 |
| 2023 4 | 68 | 2 | 70 |
| 2023 3 | 72 | 0 | 72 |
| 2023 2 | 43 | 4 | 47 |
| 2022 1 | 42 | 4 | 46 |
| 2022 12 | 26 | 7 | 33 |
| 2022 11 | 37 | 7 | 44 |
| 2022 10 | 20 | 9 | 29 |
| 2022 9 | 21 | 15 | 36 |
| 2022 8 | 21 | 8 | 29 |
| 2022 7 | 17 | 7 | 24 |
| 2022 6 | 22 | 5 | 27 |
| 2022 5 | 23 | 8 | 31 |
| 2022 4 | 43 | 10 | 53 |
| 2022 3 | 82 | 11 | 93 |
| 2022 2 | 51 | 9 | 60 |
| 2020 12 | 1 | 0 | 1 |
| 2018 5 | 1 | 3 | 4 |
| 2018 4 | 7 | 8 | 15 |
| 2018 3 | 5 | 3 | 8 |
| 2018 2 | 8 | 7 | 15 |
| 2018 1 | 3 | 6 | 9 |
| 2017 12 | 7 | 4 | 11 |
| 2017 11 | 8 | 6 | 14 |
| 2017 10 | 15 | 7 | 22 |
| 2017 9 | 22 | 8 | 30 |
| 2017 8 | 6 | 19 | 25 |
| 2017 7 | 4 | 9 | 13 |
| 2017 6 | 9 | 17 | 26 |
| 2017 5 | 8 | 16 | 24 |
| 2017 4 | 9 | 9 | 18 |
| 2017 3 | 11 | 25 | 36 |
| 2017 2 | 12 | 6 | 18 |
| 2016 1 | 4 | 3 | 7 |
| 2016 12 | 29 | 6 | 35 |
| 2016 11 | 28 | 5 | 33 |
| 2016 10 | 48 | 1 | 49 |
| 2016 9 | 10 | 4 | 14 |
| 2016 8 | 13 | 4 | 17 |
| 2016 7 | 23 | 8 | 31 |
| 2016 6 | 34 | 21 | 55 |
| 2016 5 | 34 | 7 | 41 |
| 2016 4 | 17 | 8 | 25 |
| 2016 3 | 32 | 8 | 40 |
| 2016 2 | 26 | 7 | 33 |
| 2015 1 | 20 | 10 | 30 |
| 2015 12 | 28 | 12 | 40 |
| 2015 11 | 27 | 8 | 35 |
| 2015 10 | 28 | 4 | 32 |
| 2015 9 | 36 | 5 | 41 |
| 2015 8 | 26 | 0 | 26 |
| 2015 7 | 32 | 5 | 37 |
| 2015 6 | 15 | 8 | 23 |
| 2015 5 | 23 | 4 | 27 |
| 2015 4 | 13 | 11 | 24 |
| 2015 3 | 71 | 8 | 79 |
| 2015 2 | 19 | 7 | 26 |
| 2015 1 | 30 | 6 | 36 |
| 2014 12 | 48 | 5 | 53 |
| 2014 11 | 24 | 2 | 26 |
| 2014 10 | 44 | 3 | 47 |
| 2014 9 | 31 | 1 | 32 |
| 2014 8 | 19 | 1 | 20 |
| 2014 7 | 38 | 2 | 40 |
| 2014 6 | 41 | 1 | 42 |
| 2014 5 | 28 | 2 | 30 |
| 2014 4 | 23 | 2 | 25 |
| 2014 3 | 34 | 3 | 37 |
| 2014 2 | 26 | 1 | 27 |
| 2014 1 | 33 | 2 | 35 |
| 2013 12 | 24 | 5 | 29 |
| 2013 11 | 34 | 1 | 35 |
| 2013 10 | 41 | 4 | 45 |
| 2013 9 | 35 | 7 | 42 |
| 2013 8 | 34 | 6 | 40 |
| 2013 7 | 30 | 2 | 32 |
| 2009 6 | 956 | 0 | 956 |
Mostrar todo